Results 161 to 170 of about 8,346,081 (358)

Coordinated Active-Reactive Power Management of ReP2H Systems with Multiple Electrolyzers [PDF]

, 2023
Yangjun Zeng, Buxiang Zhou, Jie Zhu, Jiarong Li, Bosen Yang, Jin Lin, Yiwei Qiu   +6 more
openalex   +1 more source

Exploring Patients’ Profiles Associated With the Resolution of Acute Calcium Pyrophosphate Arthritis Treated With Colchicine and Prednisone: Post Hoc Analysis of a Randomized Controlled Trial

Arthritis Care &Research, EarlyView.
Objective The objective was to identify factors determining acute arthritis resolution and safety with colchicine and prednisone in acute calcium pyrophosphate (CPP) crystal arthritis. Methods We conducted a post hoc analysis of the COLCHICORT trial, which compared colchicine and prednisone for the treatment of acute CPP crystal arthritis, using a ...
Tristan Pascart, Laurène Norberciak, Pascal Richette, Pierre Robinet, Aurore Pacaud, Gauthier Marchasson, Thibault Rabin, Hélène Luraschi, Pierre Maciejasz, Anne‐France Georgel, Augustin Latourte, Hang‐Korng Ea, Sébastien Ottaviani, Charlotte Jauffret, Vincent Ducoulombier   +14 more
wiley   +1 more source

Fuzzy logic-based reactive power control for power factor enhancement in EV drives. [PDF]

Sci Rep
Mohan H, Kumar A, Saxena NK, Mishra S, Khetrapal P, Azzopardi B, Jately V.   +6 more
europepmc   +1 more source

Reactive Power Regulation of Wind-Diesel Hybrid System

, 2012
P. Sivakumar, S. Thirukkovai, K. Yogeshraj, Ahmed A. Abdullah   +3 more
openalex   +1 more source

Enhanced active power filter control for nonlinear non-stationary reactive power compensation [PDF]

, 2012
Phen Chiak See, Vin Cent Taı, Marta Molinas, Kjetil Uhlen, Olav Bjarte Fosso   +4 more
openalex   +1 more source

Sarilumab in Polyarticular‐Course Juvenile Idiopathic Arthritis: Dose‐Finding and 1‐Year Analysis of a Phase 2b, Open‐Label, Multicenter Study

Arthritis Care &Research, EarlyView.
Objective This study assessed sarilumab in treating patients with polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods This phase 2b, open‐label study (NCT02776735) consisted of three sequential parts (each with a core‐treatment and extension phase).
Fabrizio De Benedetti, Inmaculada C. Penadés, Irina Nikishina, Ivan Foeldvari, Alberto J. Spindler, Anna Kozlova, Nadina Rubio‐Pérez, Pierre Quartier, Zbigniew Żuber, Raul Barria, Daniel Clemente, Gabriel V. Cornejo, Katherine Marzan, Nancy Liu, Christine Xu, Stephen DiMartino, Angeliki Giannelou, Fei Cao‐Ghoul, Bolanle Akinlade, Lydie Baret‐Cormel   +19 more
wiley   +1 more source

Grid resilience enhancement of photovoltaic systems via Lyapunov-validated active-reactive power coordination and inverter oversizing. [PDF]

Sci Rep
Kotla RW, Ganji S, Lagudu J, Yarlagadda SR, Bolli S.   +4 more
europepmc   +1 more source

Incentive Mechanism for Decentralized Reactive Power Management Through Solar Inverters

Naureen Siddiqui, Priyanka Paliwal
openalex   +1 more source

Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Belimumab in Pediatric Patients With Systemic Lupus Erythematosus: A Multicenter, Open‐Label Trial

Arthritis Care &Research, EarlyView.
Objective This study aimed to characterize the pharmacokinetics, pharmacodynamics, safety, and exploratory efficacy of subcutaneous belimumab in pediatric patients with active systemic lupus erythematosus (SLE) receiving standard therapy. Methods This single‐arm, multicenter, open‐label trial (GSK study 200908; ClinicalTrials.gov identifier ...
Hermine I. Brunner, Jordi Antón, Inmaculada Calvo‐Penadés, Richard Dimelow, Gerd Horneff, Sylvia Kamphuis, Rebecca Marino, Andre van Maurik, Kirsten Minden, Masaaki Mori, Josephine Ocran‐Appiah, Christel Wilkinson, Yuichi Yamasaki, Deepak Assudani, for the Pediatric Rheumatology Collaborative Study Group (PRCSG) and Paediatric Rheumatology International Trials Organisation (PRINTO) Network investigators   +14 more
wiley   +1 more source

A modified instantaneous reactive power algorithm for shunt compensation. [PDF]

Sci Rep
Mishra N, Gawande SP, Deshmukh S, Tan KT, Ansari K, Khan TMY, Almakayeel N, Khan WA.   +7 more
europepmc   +1 more source